Elizabeth Garner

Company: Caribou Biosciences

Job title: Associate Director - T Cell Therapeutics

Seminars:

Mastermind Session: How Can We Achieve Potency & Durability of Response for More Successful Clinical Outcomes? 11:30 am

Discussing why, when compared to the autologous approach, allogeneic therapies are experiencing major issues with durability Investigating reactivation of endogenous immunity from the patient donor’s immunity following allogeneic T-cell infusion Exploring the balance between long-lasting persistence versus the efficacy of the transient allogeneic product Discussing innovations in design and administration to develop a long acting…Read more

day: Advancing Durability & Persistence Focus Day

Using chRDNA Genome-Editing Technology to Enhance Persistence Of Allogeneic T Cell Therapies 10:00 am

Discuss chRDNAs, a next-generation CRISPR genome-editing technology Enhancing persistence of allogeneic CAR-T cell therapies through armoring strategies and immune cloakingRead more

day: Advancing Durability & Persistence Focus Day